Overall Survival With First-Line vs Second-Line CDK4/6 Inhibitor Use in Advanced Breast Cancer
已完结10由 达姆 发布于 2026/2/24 14:49:46
DOI:10.1001/jamaoncol.2025.6585
作者:Noor Wortelboer, Annemiek van Ommen-Nijhof, Inge R. Konings, Vincent van der Noort, Esther van den Pol, Cristina Guerrero Páez, Sandra D. Bakker, Sjoerd Hovenga, Alex L. T. Imholz, Yvonne J. L. Kamm,
文献类型:期刊论文
补充材料:只需要正文